Mathematically Arterialised Testing of Hypercapnic Subjects Study
MATHS
A Prospective Observational Cohort Study to Investigate the Physiological Agreement Between Arterial Sampling (the Reference Method) and Mathematically Arterialised Venous Blood
1 other identifier
observational
84
1 country
1
Brief Summary
Prospective observational cohort study of patients admitted to hospital with suspected hypercapnic respiratory failure and requiring treatment with non-invasive ventilation (NIV) as part of standard, routine management. Contemporaneous blood gas samples will be obtained via arterial, capillary, and venous methods. The venous samples will undergo mathematical arterialisation via the v-TAC system. In line with standard medical care, arterial samples will be obtained before starting NIV and at two set points afterwards (day 1 post-NIV, and pre-discharge). Pre-existing clinical thresholds will be used to assess the reliability of v-TAC against ABG, the existing gold standard and will conduct a retrospective model of decision-making once the blood sampling component of the study is concluded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2018
CompletedFirst Submitted
Initial submission to the registry
January 23, 2019
CompletedFirst Posted
Study publicly available on registry
August 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedSeptember 28, 2022
May 1, 2022
2 years
January 23, 2019
September 27, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change in blood carbon dioxide level (PaCO2)
Change in PaCO2 between the pre-NIV (non-invasive ventilation) and day 1 NIV samples for ABG (arterial blood gas) versus v-TAC (arterialised venous blood gas)
Between day 0 and day 1
Secondary Outcomes (5)
Change in PaCO2 between ABG versus v-TAC versus Capillary Blood Gas (CBG) versus Venous Blood Gas (VBG)
Between day 0 and day 1
Change in PaCO2 between ABG versus v-TAC versus Capillary Blood Gas (CBG) versus Venous Blood Gas (VBG)
Between day 0 and through to study completion, up to 3 days
Relative difficult in sampling
Between day 0 and through to study completion, up to 3 days
Patient experience
Between day 0 and through to study completion, up to 3 days
Patient preference
Between day 0 and through to study completion, up to 3 days
Eligibility Criteria
Adult patients with suspected chronic hypercapnic respiratory failure admitted as part of routine clinical care for consideration of home NIV.
You may qualify if:
- Aged 18 years or above.
- Admitted for consideration of home Non Invasive Ventilation.
- Due to undergo arterial blood gas sampling as part of routine clinical care
You may not qualify if:
- Inability to provide informed consent.
- Clinical necessity to perform blood gas sampling prior to allowing sufficient time for informed consent.
- Inability to obtain reliable SpO2 readings
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Papworth Hospital NHS Foundation Trustlead
- Aalborg Universitycollaborator
Study Sites (1)
Royal Papworth Hospital
Cambridge, Cambridgeshire, CB2 0AY, United Kingdom
Related Publications (1)
Davies MG, Wozniak DR, Quinnell TG, Palas E, George S, Huang Y, Jayasekara R, Stoneman V, Smith IE, Thomsen LP, Rees SE. Comparison of mathematically arterialised venous blood gas sampling with arterial, capillary, and venous sampling in adult patients with hypercapnic respiratory failure: a single-centre longitudinal cohort study. BMJ Open Respir Res. 2023 Jun;10(1):e001537. doi: 10.1136/bmjresp-2022-001537.
PMID: 37369550DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Davies
Royal Papworth Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 23, 2019
First Posted
August 28, 2019
Study Start
October 15, 2018
Primary Completion
October 8, 2020
Study Completion
July 31, 2021
Last Updated
September 28, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share